Business Description
Immunotech Biopharm Ltd
ISIN : KYG4721A1004
Share Class Description:
HKSE:06978: Ordinary SharesTotal Employee Number:
183Compare
Compare
Traded in other countries / regions
06978.Hong Kong IPO Date
2020-07-10Description
Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.35 | |||||
Equity-to-Asset | -0.02 | |||||
Debt-to-Equity | -31.61 | |||||
Debt-to-EBITDA | -1.98 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 14.3 | |||||
3-Year EPS without NRI Growth Rate | 7.5 | |||||
3-Year FCF Growth Rate | 25.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.08 | |||||
9-Day RSI | 37.88 | |||||
14-Day RSI | 33.29 | |||||
3-1 Month Momentum % | -40 | |||||
6-1 Month Momentum % | -79.15 | |||||
12-1 Month Momentum % | -85.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.35 | |||||
Quick Ratio | 0.34 | |||||
Cash Ratio | 0.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.3 | |||||
Shareholder Yield % | -141.34 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -42.18 | |||||
ROIC % | -19.58 | |||||
3-Year ROIIC % | -506.04 | |||||
ROC (Joel Greenblatt) % | -52.9 | |||||
ROCE % | -285.76 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -2.3 | |||||
EV-to-EBITDA | -2.3 | |||||
EV-to-FCF | -4.6 | |||||
Earnings Yield (Greenblatt) % | -43.48 | |||||
FCF Yield % | -51.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immunotech Biopharm Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | |||
| EPS (TTM) (HK$) | -0.461 | ||
| Beta | 0.4613 | ||
| 3-Year Sharpe Ratio | -0.59 | ||
| 3-Year Sortino Ratio | -0.78 | ||
| Volatility % | 78.93 | ||
| 14-Day RSI | 33.29 | ||
| 14-Day ATR (HK$) | 0.031863 | ||
| 20-Day SMA (HK$) | 0.42325 | ||
| 12-1 Month Momentum % | -85.85 | ||
| 52-Week Range (HK$) | 0.33 - 5.4 | ||
| Shares Outstanding (Mil) | 617.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Immunotech Biopharm Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Immunotech Biopharm Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Immunotech Biopharm Ltd Frequently Asked Questions
What is Immunotech Biopharm Ltd(HKSE:06978)'s stock price today?
The current price of HKSE:06978 is HK$0.39. The 52 week high of HKSE:06978 is HK$5.40 and 52 week low is HK$0.33.
When is next earnings date of Immunotech Biopharm Ltd(HKSE:06978)?
The next earnings date of Immunotech Biopharm Ltd(HKSE:06978) is .
Does Immunotech Biopharm Ltd(HKSE:06978) pay dividends? If so, how much?
Immunotech Biopharm Ltd(HKSE:06978) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Immunotech Biopharm Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers